Family Medicine · Gustine, CA
NPI
1083616817
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
581 4th Ave
Gustine, CA, 95322
Phone (209) 854-1120
Groups this clinician bills Medicare through
Medicare paid, 2024
$316K
16,671 services
Medicare patients, 2024
556
Average age 75
Drug cost, 2024
$2.1M
12,364 prescriptions
Company payments, 2025
$277
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pattabiraman B Iyer was code 99213 (office e&m - established), 2,345 times for 531 patients. In total Pattabiraman B Iyer billed 16,671 services in 79 codes, and Medicare paid $316K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 2,345 | 531 | $59.93 | $141K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 1,508 | 149 | $0.66 | $996 |
| 36415 Venipuncture Blood Collection | Office | 1,489 | 513 | $8.58 | $13K |
| J0278 Injection, amikacin sulfate, 100 mg | Office | 1,288 | 54 | $0.56 | $727 |
| 85025 Blood Count | Office | 1,135 | 497 | $7.56 | $8,577 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 968 | 57 | $0.33 | $317 |
| 99214 Office E&M - Established | Office | 814 | 436 | $72.84 | $59K |
| 83036 Blood Count | Office | 793 | 363 | $9.47 | $7,506 |
| 96372 Injection Administration | Office | 684 | 193 | $9.93 | $6,789 |
| 81001 Clinical Chemistry | Office | 567 | 368 | $3.10 | $1,757 |
| 80061 Clinical Chemistry | Office | 531 | 362 | $13.04 | $6,925 |
| 90662 Vaccine Product | Office | 231 | 229 | $80.94 | $19K |
| G0008 Administration of influenza virus vaccine | Office | 229 | 227 | $32.91 | $7,536 |
| 87086 Bacterial Culture | Office | 212 | 108 | $7.91 | $1,677 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 184 | 36 | $0.51 | $93.4 |
By year: 2022 $362K for 14,000 services; 2023 $364K for 14,481 services; 2024 $316K for 16,671 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,489 | 513 | $8.58 | $13K |
| 85025 Blood Count | 1,135 | 497 | $7.56 | $8,577 |
| 83036 Blood Count | 793 | 363 | $9.47 | $7,506 |
| 81001 Clinical Chemistry | 567 | 368 | $3.10 | $1,757 |
| 80061 Clinical Chemistry | 531 | 362 | $13.04 | $6,925 |
| 87086 Bacterial Culture | 212 | 108 | $7.91 | $1,677 |
| 87184 General Laboratory | 137 | 76 | $7.33 | $1,004 |
| 87088 Bacterial Culture | 135 | 75 | $7.93 | $1,071 |
| 85651 Clinical Chemistry | 105 | 88 | $4.14 | $435 |
| 85610 Clinical Chemistry | 49 | 30 | $4.20 | $206 |
Medicare prescription drug claims, 2024
In 2024, the drug Pattabiraman B Iyer prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,038 prescriptions and refills. In total Pattabiraman B Iyer wrote 12,364 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,038 | 2,792 | 272 | $11K |
| Atorvastatin Calcium Generic | 656 | 1,628 | 174 | $4,700 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 434 | 1,103 | 113 | $4,668 |
| Losartan Potassium Generic | 387 | 951 | 100 | $2,681 |
| Allopurinol Generic | 348 | 909 | 95 | $3,359 |
| Metformin Hcl Generic | 314 | 799 | 87 | $2,235 |
| Pantoprazole Sodium Generic | 256 | 659 | 80 | $2,702 |
| Rosuvastatin Calcium Generic | 253 | 605 | 70 | $2,668 |
| Ozempic Semaglutide | 244 | 275 | 32 | $252K |
| Prednisone Generic | 210 | 228 | 152 | $297 |
| Mounjaro Tirzepatide | 206 | 226 | 31 | $227K |
| Omeprazole Generic | 193 | 493 | 55 | $2,209 |
| Amlodipine Besylate Generic | 178 | 495 | 55 | $1,010 |
| Bisoprolol-Hydrochlorothiazide Bisoprolol/Hydrochlorothiazide | 173 | 409 | 41 | $4,054 |
| Hydrochlorothiazide Generic | 168 | 473 | 46 | $722 |
Brand drugs: 2,106 claims; generic drugs: 10,175 claims; opioid claims: 234.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pattabiraman B Iyer $277 ($277 in general payments such as food, travel and fees) from 6 companies. The largest payer was Lilly USA, LLC with $79.59.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.